America's Most Talked-About Drug Has a Surprising Secret: 69% of GLP-1 Users Are Unlikely to Admit Taking It While Americans are talking about weight-loss drugs more than ever, a national survey finds less than a third would openly admit to using one DENVER, June 16, 2026 --(BUSINESS WIRE)--Virta Health, the leader in metabolic disease reversal, today released its third annual 2026 Virta Vitals , a national survey of U.S
Jelly began hormone therapy (Ill be on testosterone replacement therapy probably for the rest of my life), and his levels were starting to even out
This precision approach transforms GLP-1 therapy from a one-size-fits-all model into a personalized strategy rooted in your unique genetic profile
Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota
They rely on random cardio
Ongoing research into nutritional and exercise interventions, as well as novel pharmacological agents such as myostatin/activin pathway inhibitors (243) or agents targeting the apelin pathway (244) holds promise for preserving lean mass and improving overall health in patients undergoing treatment with GLP-1 and dual GIP/GLP-1 receptor agonists
